New eye drops for dry eye pass safety check in small trial

NCT ID NCT06660290

Completed Symptom relief Sponsor: Alcon Research Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested the safety of AR-15512 eye drops in 55 people with dry eye disease. Participants received the drops at different temperatures and with eyes open or closed to see if these factors affect side effects. The goal was to measure how many people had eye-related side effects from the drops.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AR-15512 ophthalmic solution (also called TRYPTYR or Acoltremon)
What this could lead to: If successful, this could confirm that AR-15512 eye drops are safe and comfortable for treating dry eye disease.
What could go wrong: This is a small safety study with only 55 people, so results may not apply to everyone. It does not test how well the drops work for symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dry eye syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRY EYE DISEASE

Contacts and locations

Locations

Advancing Vision Research, LLC

Smyrna, Tennessee, 37167, United States
Andover Eye Associates

Andover, Massachusetts, 01810, United States
Eye Research Foundation

Newport Beach, California, 92663, United States
Piedmont Eye Center

Lynchburg, Virginia, 24502, United States
Total Eye Care, PA

Memphis, Tennessee, 38119, United States
Vision Institute

Colorado Springs, Colorado, 80907, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.